COMMUNIQUÉS West-GlobeNewswire

Omada Health to Announce Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025
17/07/2025
SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its second quarter 2025 results on Thursday, August 7, [...]
Hapbee Announces Insider Purchase of $1 Million USD via Closing of Non-Brokered Private Placement
17/07/2025
Follows Prior Investment by Jaylen Brown and the New Leadership Team Underscoring Growing Confidence in Hapbee VANCOUVER, British Columbia, July 17, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB | OTCID [...]
LifeStance to Host Second Quarter 2025 Earnings Conference Call on August 7, 2025
17/07/2025
SCOTTSDALE, Ariz., July 17, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, will issue its second quarter 2025 earnings [...]
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17/07/2025
CHASKA, Minn., July 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that on July 11, [...]
Exagen Inc. Appoints Chas McKhann to Board of Directors
17/07/2025
CARLSBAD, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing solutions, announced today the appointment of Chas McKhann to its Board of Directors, [...]
NKGen Biotech and HekaBio Enter Strategic Partnership to Bring Novel NK Cell Therapy to Japan
17/07/2025
In connection with HekaBio’s recently announced strategic investment in NKGen, the partnership will expedite the regulatory, manufacturing, and commercial development of NKGen’s autologous NK cell therapy, troculeucel, [...]
Updated Data from Eledon Pharmaceuticals’ Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at the World Transplant Congress 2025
17/07/2025
IRVINE, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that updated clinical data from its ongoing open-label Phase 1b study evaluating tegoprubart for [...]
Health care advocates afraid of major cuts and privatization hold shadow summit and rally at Council of the Federation next week
17/07/2025
HUNTSVILLE, Ontario, July 17, 2025 (GLOBE NEWSWIRE) -- Outside the Council of the Federation and the gathering of First Ministers, public health care advocates from across Canada will be joining a shadow summit, rally, [...]
Heartflow Unveils Landmark DECIDE Registry Data Demonstrating Impact of Heartflow Plaque Analysis on Coronary Artery Disease Medical Management
17/07/2025
More than 50% of patients saw treatment changes following Heartflow Plaque Analysis – driving promising LDL cholesterol improvements and individualized care MONTREAL, July 17, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. , [...]
OSE Immunotherapeutics lance une Newsletter pour les investisseurs individuels
17/07/2025
OSE Immunotherapeutics Launches Newsletter for Individual Shareholders NANTES, France, July 17, 2025, 6:30pm CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) , a biotech company dedicated to developing [...]
OSE Immunotherapeutics lance une Newsletter pour les investisseurs individuels
17/07/2025
OSE Immunotherapeutics lance une Newsletter pour les investisseurs individuels NANTES, France, 17 juillet 2025, 18h30 – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) , société de biotechnologie qui [...]
MYOS PET and Leading Veterinarian Urge Action as Weather Extremes Impact Senior Pet Muscle Health
17/07/2025
CEDAR KNOLLS, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- With climate changes becoming more severe, veterinary sports medicine and rehabilitation expert Dr. Kelly Fishman, DVM, CVA, CCRT, warns that summer heat waves and [...]
EssilorLuxottica: Second-Quarter and First-Half 2025 Results Conference Call Invitation
17/07/2025
Second-Quarter and First-Half 2025 Results Conference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer, Mr PAUL DU SAILLANT, Deputy Chief Executive Officer, Mr STEFANO GRASSI, Chief Financial [...]
EssilorLuxottica: Second-Quarter and First-Half 2025 Results Conference Call Invitation
17/07/2025
Second-Quarter and First-Half 2025 Results Conference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer, Mr PAUL DU SAILLANT, Deputy Chief Executive Officer, Mr STEFANO GRASSI, Chief Financial [...]
Oncotelic Therapeutics Highlights Peer‑Reviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer Patients
17/07/2025
Data support further evaluation of investigational antisense OT‑101 (trabedersen) as a TGFB2‑targeted approach in pancreatic ductal adenocarcinoma (PDAC). AGOURA HILLS, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- [...]
AI-Supported, Single-Center Cancer Model from Liv Hospital
17/07/2025
Photo: Liv Hospital via FL Communications ISTANBUL, July 17, 2025 (GLOBE NEWSWIRE) -- The “single-center oncology model,” implemented by only a select number of institutions worldwide, is being carried out with advanced [...]
Professional Credit Renews HFMA Peer Review Designation
17/07/2025
CHICAGO, July 17, 2025 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) today announced that, following rigorous review, Professional Credit has once again achieved the “Peer Reviewed by HFMA [...]
SPR to Feature Five Abstracts on SPRINT® PNS at ASPN 2025
17/07/2025
- Data on chronic postoperative knee pain to be highlighted as a top abstract along with a first-ever look at SPRINT PNS in patients with migraine pain - CLEVELAND, July 17, 2025 (GLOBE NEWSWIRE) -- Leading pain [...]
Biotricity Delivers Strong Fiscal Year 2025 Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses, Putting Profitability within Reach
17/07/2025
FY25 revenue up 14.3% YOY FY25 margins improvement of 8.9% to 76.6%, from 69.3% in the prior year; Q4-FY25 margins improved to 80.4% as margin expansion forecasted to continue FY25 operating expenses lower by 24.5% YOY [...]

Pages